Mersana Therapeutics Inc

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.…